|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.42 CNY | -0.69% |
|
-6.16% | +2.80% |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 201.11 million compared to CNY 27.66 million a year ago. Net loss was CNY 414.49 million compared to CNY 319.23 million a year ago.
Basic loss per share from continuing operations was CNY 1.73 compared to CNY 1.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.80% | 2B | |
| +55.19% | 801B | |
| +47.26% | 631B | |
| -6.09% | 359B | |
| +21.92% | 337B | |
| +18.40% | 245B | |
| +3.64% | 231B | |
| +12.98% | 219B | |
| +10.86% | 171B | |
| -2.78% | 161B |
SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. 
